Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|13|5|698-710

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.13, Iss.5, 2016-08, pp. : 698-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models - a critical analysis of clinical trials

By Ji H.   Li S.P.   Cheng X.   Cheng H.R.   Ng T.B.   Li P.   Li N.S.  

General Pharmacology, Vol. 33, Iss. 2, 1999-08 ,pp. : 207-211

Elsevier

Access to resources Recommend Favorite

Low molecular weight heparin (LMWH) is acceptable to patients with advanced cancer receiving palliative care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The Use of Borneol as an Enhancer for Targeting Aprotinin-Conjugated PEG-PLGA Nanoparticles to the Brain

By Zhang Lin   Han Limei   Qin Jing   Lu Weiyue   Wang Jianxin  

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2560-2572

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro Drug Release Behavior, Mechanism and Antimicrobial Activity of Rifampicin Loaded Low Molecular Weight PLGA-PEG-PLGA Triblock Copolymeric Nanospheres

By  

Current Drug Delivery, Vol. 10, Iss. 6, 2013-12 ,pp. : 722-731

Bentham Science Publishers

Access to resources Recommend Favorite

Heparin/low molecular weight heparins: Fatal heparin-induced thrombocytopenia and thrombosis syndrome in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite